Login / Signup

Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.

Aishwarya SGunasekaran KAnita Margret A
Published in: Journal of biomolecular structure & dynamics (2021)
The novel coronavirus disease pandemic caused by the COVID-19 virus has infected millions of people around the world with a surge in transmission and mortality rates. Although it is a respiratory viral infection that affects airway epithelial cells, a diverse set of complications, including cytokine storm, gastrointestinal disorders, neurological distress, and hyperactive immune responses have been reported. However, growing evidence indicates that the bidirectional crosstalk of the gut-lung axis can decipher the complexity of the disease. Though not much research has been focused on the gut-lung axis microbiome, there is a translocation of COVID-19 infection from the lung to the gut through the lymphatic system resulting in disruption of gut permeability and its integrity. It is believed that detailed elucidation of the gut-lung axis crosstalk and the role of microbiota can unravel the most significant insights on the discovery of diagnosis using microbiome-based-therapeutics for COVID-19. This review calls attention to relate the influence of dysbiosis caused by COVID-19 and the involvement of the gut-lung axis. It presents first of its kind details that concentrate on the momentousness of biotics in disease progression and restoration.Communicated by Ramaswamy H. Sarma.
Keyphrases
  • coronavirus disease
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • lymph node
  • risk factors
  • type diabetes
  • cardiovascular disease
  • endothelial cells
  • working memory
  • cardiovascular events